About Huma
Huma is a company based in London (United Kingdom) founded in 2011. It operates as a AI-as-a-Service, SaaS (Software-as-a-Service), and HealthTech. Huma has raised $354.93 million across 13 funding rounds from investors including Bayer, Astrazeneca and Sony Innovation Fund. Huma has completed 8 acquisitions, including Alcedis, Aluna and Amaze Health. Huma offers products and services including Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
- Headquarter London, United Kingdom
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Huma Therapeutics Limited
- Date of Incorporation 02 Aug, 2011
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$15.69 M (USD)139as on Dec 31, 2022
-
Net Profit
-$38.25 M (USD)-20as on Dec 31, 2022
-
EBITDA
-$39.21 M (USD)-15as on Dec 31, 2022
-
Total Equity Funding
$354.93 M (USD)
in 13 rounds
-
Latest Funding Round
$17.29 M (USD), Series D
Apr 25, 2025
-
Investors
Bayer
& 9 more
-
Employee Count
Not available
-
Investments & Acquisitions
Alcedis
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Huma
Huma offers a comprehensive portfolio of products and services, including Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
A foundation for digital health innovation is provided.
AI tools for healthcare transformation are being developed.
Clinical and billing information capture is automated efficiently.
Clinical productivity for nurses is significantly enhanced here.
People of Huma
Unlock access to complete
Unlock access to complete
Funding Insights of Huma
Huma has successfully raised a total of $354.93M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $17.29 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Huma
Huma has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Bayer, Astrazeneca and Sony Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and infrastructure investments are focused on multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided for technology and healthcare companies.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life sciences sector
|
Locked | Locked | Locked |
Investor details for Huma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Huma
Huma has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Alcedis, Aluna and Amaze Health.
Investment portfolio details for Huma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Smart devices and apps for children's asthma tracking are provided.
|
Locked | Locked | 2020 | Locked | |
|
Teleconsultation solutions are provided for employee healthcare access.
|
Locked | Locked | 2017 | Locked | |
|
Patient data from wearables and sensors is analyzed and measured.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Huma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Huma
Detailed financials for Huma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Huma Comparisons
Peer comparison for Huma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Huma
Detailed competitors of Huma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Huma
Complete news archive for Huma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Huma
Huma was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Huma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Huma is a funded company, having raised a total of $354.93M across 13 funding rounds to date.
Annual revenue of Huma is $15.69M as on Dec 31, 2022.
Digital and AI-first health solutions are offered by Huma, focusing on transforming healthcare through innovative technology. Products like Huma Cloud Platform, Huma Intelligence, and specific tools such as Hi Scribe and Hi Nurse are provided to enhance clinical productivity and automate documentation. The company operates in sectors including regulated digital health, life sciences, and global health systems. Solutions span remote patient monitoring, virtual wards, hospital-at-home models, AI-driven diagnostics, and clinical trial data capture. A worldwide impact is achieved, supporting nearly 100 million people across multiple continents with regulatory compliance.
Huma offers Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
Huma has made 8 acquisitions, including Alcedis, Aluna, and Amaze Health.
Huma has 10 investors. Key investors include Bayer, Astrazeneca, Sony Innovation Fund, HAT, and Hitachi Ventures.
The valuation of Huma is $592.87M as of Mar 2022.